StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Amneal Pharmaceuticals's gross margin for the twelve months ending Jun 30, 2026 was 39.3%. For fiscal 2025 it was 36.9%, against 36.5% the year before. The highest annual figure on record is 58.7% in fiscal 2016.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202536.9%+0.4
FY2024Dec 31, 202436.5%+2.2
FY2023Dec 31, 202334.3%−1.2
FY2022Dec 31, 202235.5%−1.3
FY2021Dec 31, 202136.7%+5.2
FY2020Dec 31, 202031.5%+9.8
FY2019Dec 31, 201921.7%−21.4
FY2018Dec 31, 201843.1%−7.8
FY2017Dec 31, 201750.9%−7.8
FY2016Dec 31, 201658.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202642.0%+2.5
Q1 FY2026Mar 31, 202644.3%+7.5
Q4 FY2025Dec 31, 202536.5%+0.5
Q3 FY2025Sep 30, 202534.9%−3.5
Q2 FY2025Jun 30, 202539.5%+3.9
Q1 FY2025Mar 31, 202536.8%+0.7
Q4 FY2024Dec 31, 202436.0%+5.2
Q3 FY2024Sep 30, 202438.4%+0.9
Q2 FY2024Jun 30, 202435.6%−1.1
Q1 FY2024Mar 31, 202436.1%+4.2
Q4 FY2023Dec 31, 202330.8%−4.6
Q3 FY2023Sep 30, 202337.5%+1.9
Q2 FY2023Jun 30, 202336.7%+0.9
Q1 FY2023Mar 31, 202332.0%−3.1
Q4 FY2022Dec 31, 202235.3%+4.3
Q3 FY2022Sep 30, 202235.6%−2.0
Q2 FY2022Jun 30, 202235.8%−3.9
Q1 FY2022Mar 31, 202235.1%−3.8
Q4 FY2021Dec 31, 202131.0%−1.8
Q3 FY2021Sep 30, 202137.6%+11.8
Q2 FY2021Jun 30, 202139.7%+8.7
Q1 FY2021Mar 31, 202138.8%+2.0
Q4 FY2020Dec 31, 202032.8%+5.0
Q3 FY2020Sep 30, 202025.7%+11.3
Q2 FY2020Jun 30, 202031.0%+5.0
Q1 FY2020Mar 31, 202036.8%+18.2
Q4 FY2019Dec 31, 201927.7%−11.1
Q3 FY2019Sep 30, 201914.4%−27.6
Q2 FY2019Jun 30, 201926.0%−17.1
Q1 FY2019Mar 31, 201918.6%−33.9
Q4 FY2018Dec 31, 201838.9%−12.7
Q3 FY2018Sep 30, 201842.0%−11.0
Q2 FY2018Jun 30, 201843.1%−4.5
Q1 FY2018Mar 31, 201852.5%+1.1
Q4 FY2017Dec 31, 201751.6%–
Q3 FY2017Sep 30, 201753.0%–
Q2 FY2017Jun 30, 201747.6%–
Q1 FY2017Mar 31, 201751.4%–

More Amneal Pharmaceuticals figures

See a number that looks wrong?